SCHEMBL5243418

SCHEMBL5243418

CCCc1cc(Cl)c2c(c1)CN(Cc1ccc(OC(F)(F)F)cc1)C2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
TSHR P16473 1/20 0.50
DRD4 P21917 3/20 0.39
DRD2 P14416 2/20 0.39
DRD3 P35462 2/20 0.39
SLC6A4 P31645 4/20 0.39
SLC6A3 Q01959 4/20 0.39
ACACB O00763 1/20 0.39
TNF P01375 1/20 0.38
NOD2 Q9HC29 1/20 0.38
NOD1 Q9Y239 1/20 0.38
KCNH2 Q12809 2/20 0.38
LMNA P02545 1/20 0.38
HTR2C P28335 1/20 0.38
BCHE P06276 2/20 0.37
ACHE P22303 2/20 0.37
BACE1 P56817 2/20 0.37
TRPV1 Q8NER1 1/20 0.37
LSS P48449 1/20 0.37
PHGDH O43175 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5243815 0.84 ALDH1A1 (0.52) ALDH1A1TSHRACACBTNFNOD2
SCHEMBL2025437 0.77 GRM2 (0.47) ALDH1A1TSHRHTR2CTRPV1
SCHEMBL5239908 0.77 ALDH1A1 (0.52) ALDH1A1TSHRTNFNOD2NOD1
SCHEMBL5279985 0.77 CHRM5 (0.48) ALDH1A1TSHRSLC6A4SLC6A3ACACB
SCHEMBL5243311 0.75 KMT2A (0.44) DRD4DRD2DRD3KCNH2
SCHEMBL5240643 0.75 ALDH1A1 (0.50) ALDH1A1TSHRACACBTNFNOD2
SCHEMBL5245082 0.75 KDM4E (0.40) ALDH1A1DRD4DRD2DRD3KCNH2
SCHEMBL5241430 0.74 ALDH1A1 (0.52) ALDH1A1TSHRDRD4DRD2DRD3
SCHEMBL5243643 0.73 ALDH1A1 (0.41) ALDH1A1TSHRDRD4TNFNOD2
SCHEMBL5240721 0.73 ALDH1A1 (0.50) ALDH1A1TSHRDRD4DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778634-A1 ISOINDOLONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS AstraZeneca AB (SE) 2007-05-02 EP disclosed
WO-2006020879-A1 ISOINDOLONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS ASTRAZENECA AB (SE) 2006-02-23 WO disclosed